Literature DB >> 26081141

The Putative Role of Viruses, Bacteria, and Chronic Fungal Biotoxin Exposure in the Genesis of Intractable Fatigue Accompanied by Cognitive and Physical Disability.

Gerwyn Morris1, Michael Berk2,3, Ken Walder4, Michael Maes5,6.   

Abstract

Patients who present with severe intractable apparently idiopathic fatigue accompanied by profound physical and or cognitive disability present a significant therapeutic challenge. The effect of psychological counseling is limited, with significant but very slight improvements in psychometric measures of fatigue and disability but no improvement on scientific measures of physical impairment compared to controls. Similarly, exercise regimes either produce significant, but practically unimportant, benefit or provoke symptom exacerbation. Many such patients are afforded the exclusionary, non-specific diagnosis of chronic fatigue syndrome if rudimentary testing fails to discover the cause of their symptoms. More sophisticated investigations often reveal the presence of a range of pathogens capable of establishing life-long infections with sophisticated immune evasion strategies, including Parvoviruses, HHV6, variants of Epstein-Barr, Cytomegalovirus, Mycoplasma, and Borrelia burgdorferi. Other patients have a history of chronic fungal or other biotoxin exposure. Herein, we explain the epigenetic factors that may render such individuals susceptible to the chronic pathology induced by such agents, how such agents induce pathology, and, indeed, how such pathology can persist and even amplify even when infections have cleared or when biotoxin exposure has ceased. The presence of active, reactivated, or even latent Herpes virus could be a potential source of intractable fatigue accompanied by profound physical and or cognitive disability in some patients, and the same may be true of persistent Parvovirus B12 and mycoplasma infection. A history of chronic mold exposure is a feasible explanation for such symptoms, as is the presence of B. burgdorferi. The complex tropism, life cycles, genetic variability, and low titer of many of these pathogens makes their detection in blood a challenge. Examination of lymphoid tissue or CSF in such circumstances may be warranted.

Entities:  

Keywords:  Chronic fatigue syndrome; Cognition; Depression; Immune; Inflammation; Neurology; Oxidative stress; Psychiatry; Toll-like receptor

Mesh:

Substances:

Year:  2015        PMID: 26081141     DOI: 10.1007/s12035-015-9262-7

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  306 in total

Review 1.  Is human herpesvirus-6 a trigger for chronic fatigue syndrome?

Authors:  Anthony L Komaroff
Journal:  J Clin Virol       Date:  2006-12       Impact factor: 3.168

Review 2.  Viruses and apoptosis.

Authors:  V O'Brien
Journal:  J Gen Virol       Date:  1998-08       Impact factor: 3.891

3.  The Epstein-Barr virus immediate-early protein BZLF1 regulates p53 function through multiple mechanisms.

Authors:  Amy Mauser; Shin'ichi Saito; Ettore Appella; Carl W Anderson; William T Seaman; Shannon Kenney
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

Review 4.  Human B-lymphotropic virus (human herpesvirus-6).

Authors:  D V Ablashi; S F Josephs; A Buchbinder; K Hellman; S Nakamura; T Llana; P Lusso; M Kaplan; J Dahlberg; S Memon
Journal:  J Virol Methods       Date:  1988-09       Impact factor: 2.014

5.  Mycoplasma pneumoniae infection induces reactive oxygen species and DNA damage in A549 human lung carcinoma cells.

Authors:  Gongping Sun; Xuefeng Xu; Yingshuo Wang; Xiaoyun Shen; Zhimin Chen; Jun Yang
Journal:  Infect Immun       Date:  2008-07-28       Impact factor: 3.441

6.  The U95 protein of human herpesvirus 6B interacts with human GRIM-19: silencing of U95 expression reduces viral load and abrogates loss of mitochondrial membrane potential.

Authors:  W M Yeo; Yuji Isegawa; Vincent T K Chow
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

7.  Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay.

Authors:  H Kimura; M Morita; Y Yabuta; K Kuzushima; K Kato; S Kojima; T Matsuyama; T Morishima
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

8.  Air pollution and brain damage.

Authors:  Lilian Calderón-Garcidueñas; Biagio Azzarelli; Hilda Acuna; Raquel Garcia; Todd M Gambling; Norma Osnaya; Sylvia Monroy; Maria Rosario DEL Tizapantzi; Johnny L Carson; Anna Villarreal-Calderon; Barry Rewcastle
Journal:  Toxicol Pathol       Date:  2002 May-Jun       Impact factor: 1.902

9.  Phagocytosis of Borrelia burgdorferi, the Lyme disease spirochete, potentiates innate immune activation and induces apoptosis in human monocytes.

Authors:  Adriana R Cruz; Meagan W Moore; Carson J La Vake; Christian H Eggers; Juan C Salazar; Justin D Radolf
Journal:  Infect Immun       Date:  2007-10-15       Impact factor: 3.441

10.  Inhibition of p53-dependent, but not p53-independent, cell death by U19 protein from human herpesvirus 6B.

Authors:  Emil Kofod-Olsen; Janni M L Møller; Mariane H Schleimann; Bettina Bundgaard; Rasmus O Bak; Bodil Øster; Jacob G Mikkelsen; Ted Hupp; Per Höllsberg
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

View more
  6 in total

1.  Non-Thyroidal Illness Syndrome in Patients Exposed to Indoor Air Dampness Microbiota Treated Successfully with Triiodothyronine.

Authors:  Taija Liisa Somppi
Journal:  Front Immunol       Date:  2017-08-07       Impact factor: 7.561

Review 2.  Clinical Diagnosis of the Dampness and Mold Hypersensitivity Syndrome: Review of the Literature and Suggested Diagnostic Criteria.

Authors:  Ville Valtonen
Journal:  Front Immunol       Date:  2017-08-10       Impact factor: 7.561

3.  Whole blood gene expression in adolescent chronic fatigue syndrome: an exploratory cross-sectional study suggesting altered B cell differentiation and survival.

Authors:  Chinh Bkrong Nguyen; Lene Alsøe; Jessica M Lindvall; Dag Sulheim; Even Fagermoen; Anette Winger; Mari Kaarbø; Hilde Nilsen; Vegard Bruun Wyller
Journal:  J Transl Med       Date:  2017-05-11       Impact factor: 5.531

4.  The presence of overlapping quality of life symptoms in primary antibody deficiency (PAD) and chronic fatigue syndrome (CFS).

Authors:  Rhea A Bansal; Susan Tadros; Amolak S Bansal
Journal:  Allergy Asthma Clin Immunol       Date:  2020-03-30       Impact factor: 3.406

Review 5.  Diagnostic and Pharmacological Potency of Creatine in Post-Viral Fatigue Syndrome.

Authors:  Sergej M Ostojic
Journal:  Nutrients       Date:  2021-02-04       Impact factor: 5.717

6.  Cellular Immune Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

Authors:  Jacqueline M Cliff; Elizabeth C King; Ji-Sook Lee; Nuno Sepúlveda; Asia-Sophia Wolf; Caroline Kingdon; Erinna Bowman; Hazel M Dockrell; Luis Nacul; Eliana Lacerda; Eleanor M Riley
Journal:  Front Immunol       Date:  2019-04-16       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.